| abstract |
The present disclosure relates generally to use of crosslinked cation-binding polymers containing carboxylic acid groups for treatment of heart failure and associated symptoms and conditions. In particular, the disclosed polymers, and compositions, formulations, and dosage forms containing the polymers, may be used to treat ion and/or fluid imbalances associated with heart failure. |